Drug Shortage Report for SPASMHALT-8
Report ID | 38087 |
Drug Identification Number | 02237578 |
Brand name | SPASMHALT-8 |
Common or Proper name | SPASMHALT-8 325mg ACET/8mg COD CAPL 50 |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ACETAMINOPHEN METHOCARBAMOL CODEINE PHOSPHATE |
Strength(s) | 325MG 400MG 8MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-02-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-02-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2018-02-02 | English | Compare |
v2 | 2018-02-01 | French | Compare |
v1 | 2018-02-01 | English | Compare |
Showing 1 to 3 of 3